Laika D Aguinaldo1, Shayla Sullivant2, Elizabeth C Lanzillo3, Abigail Ross4, Jian-Ping He3, Andrea Bradley-Ewing2, Jeffrey A Bridge5, Lisa M Horowitz3, Elizabeth A Wharff6. 1. Department of Psychiatry, University of California, San Diego, 9500 Gilman Drive (MC 0862), La Jolla, CA 92093, USA. Electronic address: laaguinaldo@health.ucsd.edu. 2. Children's Mercy Kansas City, 2401 Gillham Rd, Kansas City, MO 64108, USA. 3. National Institute of Mental Health, 10 Center Drive, Bethesda, MD 20892, USA. 4. Graduate School of Social Service, Fordham University, 113 W 60th St #7, New York, NY 10023, USA. 5. The Abigail Wexner Research Institute at Nationwide Children's Hospital, 575 Children's Crossroad, Columbus, OH 43215, USA; Department of Pediatrics, Ohio State University, 370 W. 9th Avenue, Columbus, OH 43210, USA. 6. Department of Psychiatry, Boston Children's Hospital, 300 Longwood Avenue, Boston, MA 02115, USA; Department of Psychiatry, Harvard Medical School, 401 Park Drive, Boston, MA 02215, USA.
Abstract
OBJECTIVE: Validate the Ask Suicide-Screening Questions (ASQ) with youth in outpatient specialty and primary care clinics. METHOD: This is a cross sectional instrument validation study assessing the validity of the ASQ with respect to the standard criterion, Suicidal Ideation Questionnaire (SIQ/SIQ Jr.). The sample included 515 English speaking youth ages 10-21 years old from outpatient specialty and primary care clinics. ASQ sensitivity, specificity, positive and negative predictive values (PPV/NPV), positive and negative likelihood ratios, c statistic and respective receiver operating characteristic curves were assessed. RESULTS: A total of 335 outpatient specialty and 180 primary care clinic participants completed the study. In outpatient specialty clinics, the ASQ showed a sensitivity of 100.0% (95% CI: 80.5-100.0%), specificity of 91.2% (95% CI: 87.5-94.1%), and NPV of 100.0% (95% CI: 98.7-100.0). In the primary care clinic, the ASQ showed a sensitivity of 100.0% (95% CI: 59.0-100.0%), specificity of 87.9% (95% CI: 82.0-92.3%), and NPV of 100.0% (95% CI: 97.7-100.0). Forty-five (13.4%) outpatient specialty clinic participants and 28 (15.6%) primary care clinic participants screened positive for suicide risk on the ASQ. CONCLUSIONS: The ASQ is a valid screening tool for identifying youth at elevated suicide risk in outpatient clinical settings.
OBJECTIVE: Validate the Ask Suicide-Screening Questions (ASQ) with youth in outpatient specialty and primary care clinics. METHOD: This is a cross sectional instrument validation study assessing the validity of the ASQ with respect to the standard criterion, Suicidal Ideation Questionnaire (SIQ/SIQ Jr.). The sample included 515 English speaking youth ages 10-21 years old from outpatient specialty and primary care clinics. ASQ sensitivity, specificity, positive and negative predictive values (PPV/NPV), positive and negative likelihood ratios, c statistic and respective receiver operating characteristic curves were assessed. RESULTS: A total of 335 outpatient specialty and 180 primary care clinic participants completed the study. In outpatient specialty clinics, the ASQ showed a sensitivity of 100.0% (95% CI: 80.5-100.0%), specificity of 91.2% (95% CI: 87.5-94.1%), and NPV of 100.0% (95% CI: 98.7-100.0). In the primary care clinic, the ASQ showed a sensitivity of 100.0% (95% CI: 59.0-100.0%), specificity of 87.9% (95% CI: 82.0-92.3%), and NPV of 100.0% (95% CI: 97.7-100.0). Forty-five (13.4%) outpatient specialty clinic participants and 28 (15.6%) primary care clinic participants screened positive for suicide risk on the ASQ. CONCLUSIONS: The ASQ is a valid screening tool for identifying youth at elevated suicide risk in outpatient clinical settings.
Authors: Kimberly A Van Orden; Tracy K Witte; Kelly C Cukrowicz; Scott R Braithwaite; Edward A Selby; Thomas E Joiner Journal: Psychol Rev Date: 2010-04 Impact factor: 8.934
Authors: Brian K Ahmedani; Gregory E Simon; Christine Stewart; Arne Beck; Beth E Waitzfelder; Rebecca Rossom; Frances Lynch; Ashli Owen-Smith; Enid M Hunkeler; Ursula Whiteside; Belinda H Operskalski; M Justin Coffey; Leif I Solberg Journal: J Gen Intern Med Date: 2014-02-25 Impact factor: 5.128
Authors: Elizabeth C Lanzillo; Lisa M Horowitz; Elizabeth A Wharff; Arielle H Sheftall; Maryland Pao; Jeffrey A Bridge Journal: Hosp Pediatr Date: 2019-03-11
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Anne E Rhodes; Saba Khan; Michael H Boyle; Lil Tonmyr; Christine Wekerle; Deborah Goodman; Jennifer Bethell; Bruce Leslie; Hong Lu; Ian Manion Journal: Can J Psychiatry Date: 2013-05 Impact factor: 4.356
Authors: Khyati Brahmbhatt; Brian P Kurtz; Khalid I Afzal; Lisa L Giles; Elizabeth D Kowal; Kyle P Johnson; Elizabeth Lanzillo; Maryland Pao; Sigita Plioplys; Lisa M Horowitz Journal: Psychosomatics Date: 2018-09-22 Impact factor: 2.386
Authors: Lisa M Horowitz; Jeffrey A Bridge; Mary V Tipton; Ted Abernathy; Annabelle M Mournet; Deborah J Snyder; Elizabeth C Lanzillo; Daniel Powell; Michael Schoenbaum; Khyati Brahmbhatt; Maryland Pao Journal: Acad Pediatr Date: 2022-03 Impact factor: 3.107
Authors: Lynsay Ayer; Lisa M Horowitz; Lisa Colpe; Nathan J Lowry; Patrick C Ryan; Edwin Boudreaux; Virna Little; Stephen Erban; Soett Ramirez-Estrada; Michael Schoenbaum Journal: J Acad Consult Liaison Psychiatry Date: 2022-05-23
Authors: Laika D Aguinaldo; Aimee Goldstone; Brant P Hasler; David A Brent; Clarisa Coronado; Joanna Jacobus Journal: Psychiatry Res Date: 2021-02-23 Impact factor: 3.222
Authors: Brent R Crandal; Laika D Aguinaldo; Chelsea Carter; Glenn F Billman; Kendall Sanderson; Cynthia Kuelbs Journal: J Pediatr Date: 2021-10-22 Impact factor: 4.406
Authors: Margaret Ngai; Kathleen Delaney; Barbara Limandri; Kristin Dreves; Mary V Tipton; Lisa M Horowitz Journal: J Child Adolesc Psychiatr Nurs Date: 2021-06-10